MELANOMA TABLE OF CONTENTS RESEARCH SUMMARY ...................................4 Integrating the Melanoma 31-gene Expression Profile Test with Clinical and Pathologic Features Can Provide Personalized Precision Estimates for Sentinel Lymph Node Positivity: an Independent Performance Cohort NEWS AND TRENDS ...............................18 Latest News Updates in Melanoma DIGITAL RESOURCE CENTER.................19 Resources and Events in Melanoma Research and Practice JOURNAL STAFF Managing Editor, Hot Topics Austin K. Vitelli Director Emily A. Scullin Chief Medical Officer Giselle J. Geddes, MD Senior Vice President Joseph J. Morris Associate Director of Business Development Courtney McKinney Associate Director of Business Development Morgan Rinnier Data Analyst Andrew Daly Project Manager Kim Hooven Partner Patrick D. Scullin MEETING HIGHLIGHTS ..................................5 EADV 2024—Summaries of Abstracts from the Meeting Managing Editor, Dermatology Julia E. Eckert Associate Editor Amanda Tolvaisa Associate Editor Gannon R. Vitelli Assistant Editor Diana Dopheide BUSINESS STAFF Director Joseph Scullin Director E. Patrick Scullin ORIGINAL RESEARCH ....................................9 Routine Imaging Guided by a 31-gene Expression Profile Assay Results in Earlier Detection of Melanoma with Decreased Metastatic Tumor Burden Compared to Patients without Surveillance Imaging Studies JOURNAL WATCH .........................................16 Highlights of Recently Published Research in Melanoma ©2024 Matrix Medical Communications. All rights reserved. This journal is a topic-specific publication that compiles and summarizes peer-reviewed, previously published content for physicians with an interest in breast cancer management. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Matrix Medical Communications, the editorial staff, or any member of the company’s editorial advisory boards. Matrix Medical Communications is not responsible for accuracy of dosages given in the articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Matrix Medical Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. Matrix Medical Communications, LLC 1595 Paoli Pike • Ste 201 • West Chester, PA 19380 • Toll-free: (866) 325-9907 (484) 266-0702 • info@matrixmedcom.com Hot Topics in Melanoma [November 2024] 3
Journal of Clinical and Aesthetic Dermatology Hot Topics in Melanoma November 2024: Page 3
